A novel microencapsulated peptide vaccine against hepatitis B. (Q52020177)

19 April 2018

title

A novel microencapsulated peptide vaccine against hepatitis B. (English)

1 reference

19 April 2018

1 reference

Moynihan JS

1

1 reference

19 April 2018

Jones DH

series ordinal

2

1 reference

19 April 2018

Farrar GH

series ordinal

3

1 reference

19 April 2018

Howard CR

series ordinal

4

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 April 2001

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

19

1 reference

19 April 2018

issue

23-24

1 reference

19 April 2018

page(s)

3292-3300

1 reference

19 April 2018

Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

A topological model for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Immunological characteristics of a recombinant hepatitis B virus-derived multiple-epitope polypeptide: a study in polyvalent vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900540-5

7 January 2021

10.1016/S0264-410X(00)00540-5

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

11312028

1 reference

19 April 2018